Medical devices, healthcare technology and the business of care
510(k) clearance · K260313

MD-6000S Bladder Scanner

MEDA Co., Ltd. · Decision date Sep 24, 2026

MEDTECHLEDGER EXPLANATIONK260313

What did the FDA decide?

FDA recorded a substantially equivalent (SESE) decision on 2026-09-24 for K260313, a traditional 510(k) submitted by MEDA Co., Ltd. of Tianjin, CN, and received on 01/30/2026. The device is the MD-6000S Bladder Scanner, listed under device classification name System, Imaging, Pulsed Echo, Ultrasonic, regulation number 892.1560, product code IYO with subsequent product code ITX, in the Radiology specialty and review panel. The record states the review was not conducted by a third party and was not a combination product.

The FDA document describes the MD-6000S as a B-mode pulsed-echo ultrasound device intended to measure bladder volume, for use in medical and nursing care institutions by appropriately trained users. SESE means the submission was cleared as substantially equivalent; it is not a PMA approval. The record does not state the predicate device, the basis for the equivalence determination, or any performance data, so the clinical evidence behind the clearance remains unknown from these sources.

The listed documents also include unrelated search-result content, including a reference to a BioCon-1100 device, which is not described here as part of this clearance. No summary statement text was captured for K260313, and no labeling, indications beyond the quoted intent, or postmarket obligations can be confirmed from the available material.

Regulatory pathway
510(k) premarket notification
Clinical specialty
Radiology
Decision date
Sep 24, 2026

FDA source record · MedtechLedger’s explanation describes the recorded change.

Regulatory record facts

Identifier
K260313
Regulatory pathway
510(k) premarket notification
Product code
IYO
Decision code
SESE
Decision date
Sep 24, 2026
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: System, Imaging, Pulsed Echo, Ultrasonic.

Product code
IYO
FDA device class
2

FDA decision timeline

  1. K260313 received

    Application receipt date recorded by FDA.

  2. K260313 · FDA decision

    SESE

Related devices and submissions

Explore the linked device profile

Other records with product code IYO

Product / regulatory recordCompanyPathwayDecision dateSource
Evident Vascular, Inc.510(k) clearanceOct 28, 2026FDA
Accuro XVK262093
Rivanna Medical, Inc.510(k) clearanceOct 20, 2026FDA
Lilium Otsuka Co., Ltd.510(k) clearanceOct 16, 2026FDA

A shared product code identifies a classification relationship; it does not establish clinical equivalence.

Regulatory context

A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

MEDA Co., Ltd.

Headquarters
Not reported
Brand website
Not reported
FDA applicant address
Tianjin

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records